1. OS12.2 Targeting epigenetic pathways in the treatment of recurrent high-grade glioma. (6th September 2019) Authors: Hau, A; Houben, L; Klein, E; Oudin, A; Stieber, D; Flies, B; Kaoma, T; Azuaje, F; Fritah, S; Bjerkvig, R; Hertel, F; Mittelbronn, M; Golebiewska, A; Niclou, S P Journal: Neuro-oncology Issue: Volume 21(2019)Supplement 3 Page Start: iii22 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
2. P04.64 Molecular characterization of glioma patient derived orthotopic xenografts to improve outcome of preclinical studies. (19th September 2018) Authors: Golebiewska, A; Hau, A; Oudin, A; Houben, L; Stieber, D; Azuaje, F; Kaony, T; Muller, A; Hertel, F; Mittelbronn, M; Bjerkvig, R; Niclou, S P Journal: Neuro-oncology Issue: Volume 20(2018)Supplement 3 Page Start: iii294 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
3. P10.21.B Pharmacogenomics profiling of gliomas for precision medicine. (5th September 2022) Authors: Lipsa, A; Hau, A; Ermini, L; Toth, R; Oudin, A; Klink, B; Hertel, F; Mittelbronn, M; Golebiewska, A; Niclou, S Journal: Neuro-oncology Issue: Volume 24(2022)Supplement 2 Page Start: ii53 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
4. P11.09 Pan-RTK inhibition of sLRIG1 mediates AXL downregulation in Glioblastoma. (6th September 2019) Authors: Neirinckx, V; Hau, A; Schuster, A; Fritah, S; Chevigné, A; Schmidt, M H H; Niclou, S P Journal: Neuro-oncology Issue: Volume 21(2019)Supplement 3 Page Start: iii44 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗